Current evidence for safety and efficacy of anti-programmed cell-death 1 agents in the treatment of cutaneous squamous cell carcinoma: A systematic review.

Authors :: Sadowsky LM
Kosche C
West DP
Choi JN
Source :: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Feb; Vol. 82 (2), pp. 522-524. Date of Electronic Publication: 2019 Sep 26.
Publication Year :: 2020

Subjects :: Adolescent
Adult
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Treatment Outcome
Young Adult
Carcinoma, Squamous Cell drug therapy
Programmed Cell Death 1 Receptor antagonists & inhibitors
Skin Neoplasms drug therapy

Full Text Access

Tools